|40.32||+2.33||+6.13%||Vol 4.55M||1Y Perf -73.85%|
|Aug 12th, 2022 16:00 DELAYED|
|- -||0.01 0.02%|
|Target Price||53.50||Analyst Rating||Hold 2.59|
|Potential %||32.69||Finscreener Ranking||★★★★ 54.22|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★★ 54.92|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★+ 53.43|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||10.00||Earnings Rating||Strong Sell|
|Market Cap||6.52B||Earnings Date||27th Jul 2022|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-0.70|
|EPS Growth Next 5 Years %||27.30|
|Avg. Weekly Volume||5.11M|
|Avg. Monthly Volume||5.73M|
|Avg. Quarterly Volume||5.73M|
Teladoc Health Inc. (NYSE: TDOC) stock closed at 40.32 per share at the end of the most recent trading day (a 6.13% change compared to the prior day closing price) with a volume of 4.55M shares and market capitalization of 6.52B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 3276 people. Teladoc Health Inc. CEO is Jason N. Gorevic.
The one-year performance of Teladoc Health Inc. stock is -73.85%, while year-to-date (YTD) performance is -56.09%. TDOC stock has a five-year performance of 32.85%. Its 52-week range is between 27.38 and 156.82, which gives TDOC stock a 52-week price range ratio of 10.00%
Teladoc Health Inc. currently has a PE ratio of -0.60, a price-to-book (PB) ratio of 1.01, a price-to-sale (PS) ratio of 2.75, a price to cashflow ratio of 27.60, a PEG ratio of 2.32, a ROA of -83.42%, a ROC of -78.82% and a ROE of -97.62%. The company’s profit margin is -14.77%, its EBITDA margin is -431.20%, and its revenue ttm is $2.23 Billion , which makes it $13.82 revenue per share.
Of the last four earnings reports from Teladoc Health Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.70 for the next earnings report. Teladoc Health Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Teladoc Health Inc. is Hold (2.59), with a target price of $53.5, which is +32.69% compared to the current price. The earnings rating for Teladoc Health Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Teladoc Health Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Teladoc Health Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 25.92, ATR14 : 3.26, CCI20 : 21.62, Chaikin Money Flow : 0.25, MACD : -0.06, Money Flow Index : 55.15, ROC : -6.75, RSI : 43.24, STOCH (14,3) : 71.76, STOCH RSI : 1.00, UO : 46.26, Williams %R : -28.24), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Teladoc Health Inc. in the last 12-months were: Adam C. Vandervoort (Option Excercise at a value of $0), Adam C. Vandervoort (Sold 12 042 shares of value $1 381 642 ), Andrew Turitz (Option Excercise at a value of $0), Andrew Turitz (Sold 1 334 shares of value $89 027 ), Arnnon Geshuri (Sold 26 430 shares of value $2 603 695 ), Catherine A. Jacobson (Option Excercise at a value of $0), Catherine Jacobson (Option Excercise at a value of $0), Christopher Bischoff (Option Excercise at a value of $0), Claus Torp Jensen (Option Excercise at a value of $0), Claus Torp Jensen (Sold 2 051 shares of value $77 620 ), Daniel Trencher (Option Excercise at a value of $223 000), Daniel Trencher (Sold 15 439 shares of value $1 489 482 ), David B. Snow (Option Excercise at a value of $0), Jason N. Gorevic (Option Excercise at a value of $0), Jason N. Gorevic (Sold 10 000 shares of value $1 508 389 ), Karen L. Daniel (Option Excercise at a value of $0), Karen L. Daniel (Sold 519 shares of value $25 355 ), Mala Murthy (Option Excercise at a value of $0), Mala Murthy (Sold 10 770 shares of value $623 037 ), Mark Douglas Smith (Option Excercise at a value of $0), Richard J. Napolitano (Option Excercise at a value of $0), Richard J. Napolitano (Sold 824 shares of value $64 813 ), Sandra L. Fenwick (Option Excercise at a value of $0), Sandra L. Fenwick (Sold 3 587 shares of value $502 180 ), Stephany Verstraete (Option Excercise at a value of $38 550), Stephany Verstraete (Sold 4 774 shares of value $406 115 ), Thomas G. McKinley (Option Excercise at a value of $0), William H. Frist (Option Excercise at a value of $45 075)
Wed, 03 Aug 2022 01:49 GMT Teladoc Stock: Unhealthy Net Loss Means More Downside is Probable- TipRanks. All rights reserved.
Sun, 24 Jul 2022 09:10 GMT Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC) and Hookipa Pharma (HOOK)- TipRanks. All rights reserved.
Mon, 23 May 2022 15:20 GMT Teladoc Health Stock: Looks Cheap but Lacks Profitability- TipRanks. All rights reserved.
Fri, 29 Apr 2022 14:29 GMT Has Teladoc Stock Hit Bottom Looking for the Silver Lining- TipRanks. All rights reserved.
Thu, 28 Apr 2022 17:25 GMT Teladoc Stock: Time to Reconsider- TipRanks. All rights reserved.
Thu, 28 Apr 2022 12:45 GMT Teladoc (TDOC) was Downgraded to a Hold Rating at Leerink Partners- TipRanks. All rights reserved.
Thu, 07 Apr 2022 17:51 GMT Why Teladoc is More than a Pandemic Play- TipRanks. All rights reserved.
Mon, 28 Mar 2022 13:57 GMT Teladoc Health: 2 Reasons for Bullishness- TipRanks. All rights reserved.
Fri, 25 Mar 2022 18:52 GMT Teladoc: Large Dip, but Company is Still Profitless- TipRanks. All rights reserved.
Fri, 04 Mar 2022 13:20 GMT Understanding Teladocs Newly Added Risk Factors- TipRanks. All rights reserved.
Sun, 27 Feb 2022 08:17 GMT Teladoc: Healthier than it Seems- TipRanks. All rights reserved.
Sun, 06 Feb 2022 15:47 GMT Teladoc Health: Are Shares Over-Diluted- TipRanks. All rights reserved.
Thu, 27 Jan 2022 16:12 GMT Teladoc Stock: Can It Finally Rebound from Here- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.